Kusajili – Clinical trials directory

Result of your search per sponsor: Department of Endocrine Oncology

Woman and Man Max 99 years
Department of Endocrine Oncology Update Il y a 4 ans

An open, non-randomized phase-2 study of efficacy and safety of treatment with 177Lutetium-DOTA0-Tyr3-octreotate in patients with neuroendocrine tumors Clarify the effect of the treatment with 177-Lu-DOTA-octreotate, regarding a) tumour size b) biochemical response, c) prognostic factors such as proliferation markers and LD/ALP and type of tumour, d)...

Country None
organs None
Specialty None

unknown

More information